GlassScriptPhysician profile
Dana M Hess
NPI 1255562971
$3,131.49
in general payments reported to CMS, 2019-2025
20 companies · $809 in 2025
The $809 reported for 2025 was more than what 87% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $210 · 2022: $579 · 2023: $695 · 2024: $838 · 2025: $809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,183 · Education: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,182.57 |
| Education | $159.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,065.81 | 2021-2025 | |
| Janssen Biotech, INC. | $538.47 | 2022-2025 | Tremfya |
| Merz North America, INC. | $392.92 | 2024 | |
| Botanix Sb INC | $188.34 | 2025 | Sofdra |
| Allergan, INC. | $182.77 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $135.09 | 2021-2023 | Ilumya |
| Almirall LLC | $103.10 | 2021-2025 | Klisyri, Seysara |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $94.17 | 2022-2025 | Jublia, Cabtreo, Arazlo |
| E.R. Squibb & Sons, L.L.C. | $93.54 | 2023-2025 | Sotyktu |
| Novartis Pharmaceuticals Corporation | $85.26 | 2021-2022 | |
| Incyte Corporation | $42.07 | 2021-2023 | Opzelura |
| Leo Pharma INC. | $40.28 | 2021-2022 | |
| Lilly USA, LLC | $33.53 | 2023 | Taltz |
| Pfizer INC. | $31.94 | 2021 | |
| Galderma Laboratories, L.P. | $25.26 | 2021-2023 | Aklief, Epsolay, Oracea |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $24.09 | 2022 | |
| Journey Medical Corporation | $20.40 | 2025 | |
| Endo Pharmaceuticals INC. | $15.94 | 2022 | |
| Hartmann USA, INC. | $14.25 | 2021 | |
| Organon LLC | $4.26 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dana Hess listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.